68 results on '"Hopkins, P.M."'
Search Results
2. Cardiac muscle physiology
3. Combined Heart-Lung-Liver Transplantation for Patients With Cystic Fibrosis: The Australian Experience
4. Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient
5. Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactions
6. Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendations
7. Penicillin allergy de-labelling ahead of elective surgery: feasibility and barriers
8. Genetic epidemiology of malignant hyperthermia in the UK
9. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1
10. Assessing the pathogenicity of RYR1 variants in malignant hyperthermia
11. Does regional anaesthesia improve outcome?
12. Teicoplanin allergy – an emerging problem in the anaesthetic allergy clinic
13. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility
14. Peripheral regional anaesthesia and outcome: lessons learned from the last 10 years
15. Effect of concentration of local anaesthetic solution on the ED50 of bupivacaine for supraclavicular brachial plexus block
16. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis
17. What is the ED95 of prilocaine for femoral nerve block using ultrasound?
18. Malignant hyperthermia: pharmacology of triggering
19. Effect of body mass index on the ED50 volume of bupivacaine 0.5% for supraclavicular brachial plexus block
20. Genetic variation in RYR1 and malignant hyperthermia phenotypes
21. Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility
22. Pharmacogenomic variability and anaesthesia
23. Malignant hyperthemia
24. Resolution of Severe Ischemia–Reperfusion Injury Post–Lung Transplantation After Administration of Endobronchial Surfactant
25. Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia
26. Halothane and sevoflurane inhibit Na/Ca exchange current in rat ventricular myocytes
27. Transient and sustained changes in myofilament sensitivity to Ca2+ contribute to the inotropic effects of sevoflurane in rat ventricle
28. Heat stroke: implications for critical care and anaesthesia
29. Malignant hyperthermia: advances in clinical management and diagnosis
30. Bioactive roles of carotenoids and retinoids in crustaceans.
31. Limb Regeneration in the Fiddler Crab, Uca pugilator: Histological, Physiological and Molecular...
32. Diagnosing malignant hyperthermia susceptibility.
33. (458) - Cost Effectiveness of Ex Vivo Lung Perfusion Warrants Analysis of Long Term Recipient Outcome and Donor Organ Utilization Rate.
34. Evidence for related myopathies in exertional heat stroke and malignant hyperthermia.
35. A case of malignant hyperthermia?
36. Prolonged non-invasive ventilatory support prior to pulmonary transplantation does not affect postoperative outcome.
37. Caffeine and ryanodine differentially modify a calcium-dependent component of soma action potentials in identified molluscan ( Lymnaea stagnalis) neurones In situ
38. The effects of benzamil on in vitro contracture responses of human skeletal muscle to halothane
39. Low concentrations of caffeine raise intracellular calcium concentration only in the presence of extracellular calcium in cultured molluscan neurons
40. Continuous infusion of aldosterone: Correlates of body weight gain
41. MUSCLE RELAXATION RATES IN INDIVIDUALS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
42. RYANODINE CONTRACTURE: A POTENTIALLY SPECIFIC IN VITRO DIAGNOSTIC TEST FOR MALIGNANT HYPERTHERMIA
43. COMPARISON OF IN VITRO CONTRACTURE TESTING WITH RYANODINE, HALOTHANE AND CAFFEINE IN MALIGNANT HYPERTHERMIA AND OTHER NEUROMUSCULAR DISORDERS
44. IS THE “K-TYPE” CAFFEINE-HALOTHANE RESPONDER SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA ?
45. GENETIC LINKAGE ANALYSIS OF CHROMOSOME 19 MARKERS IN MALIGNANT HYPERTHERMIA
46. Prediction of outcomes in 150 patients having microvascular free tissue transfers to the head and neck
47. Increasing the likelihood of success of brachial plexus block.
48. Do in vitro pharmacological challenge responses differ between muscle specimens from malignant hyperthermia probands and their susceptible relatives?
49. Drug allergy labels in elective surgical patients: what do patients and their anaesthetists think about penicillin allergy labels?
50. Comparison of Estimated Energy Requirements in Lung Transplant Candidates.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.